Investors

People are different and so is their cancer, patients should be treated individually.

New The power of precision, For Every Oncologist, Today

With IndiTreat, 2cureX makes the testing of chemotherapeutic agents on patient-derived microtumors an operational reality.

Latest News

IGNITE update – Eight hospitals have been enrolled in the program

Rights Issue 2019

Memorandum

Please click here to download our Memorandum (Swedish)

Teaser

Please click here to download our Teaser

2cureX video interview, Finwire sitdown with 2cureX

Upcoming events

May 24, 2022

Interim Report Q1 2022 released

View previous reports

May 24, 2022

Annual General Meeting

Watch past presentations

August 25, 2022

Interim Report Q2 2022 released

View previous reports

November 24, 2022

Interim Report Q3 2022 released

View previous reports